PHIBRO ANIMAL HEALTH CORP
Financial highlights
| Metric | FY June 30, 2025 | FY June 30, 2024 | FY June 30, 2023 | FY June 30, 2022 | FY June 30, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.0B | $977.9M | $942.3M | $833.4M |
| Gross profit | $399.9M | $313.1M | $298.2M | $285.4M | $271.4M |
| Operating income | $110.5M | $53.3M | $71.8M | $79.0M | $74.9M |
| Cost of revenue | $896.3M | $704.6M | $679.7M | $656.9M | $562.0M |
| Cash from operations | $80.1M | $87.6M | $13.3M | $31.6M | $48.3M |
| Capital expenditure | $38.3M | $41.2M | $51.8M | $37.0M | $29.3M |
| Free cash flow | $41.8M | $46.4M | -$38.5M | -$5.4M | $19.0M |
| Impairments | $5.3M | — | — | — | — |
| Total assets | $1.4B | $982.2M | $971.4M | $931.7M | $841.3M |
| Total liabilities | $1.1B | $725.5M | $688.9M | $669.3M | $602.8M |
| Total debt | $725.1M | $313.1M | $335.4M | $288.8M | — |
Shares outstanding 40.6M · Free float 1.7%
Annual filing data through FY ended June 30, 2025; float as of July 12, 2026.